Diseases, Conditions, Syndromes

Coronavirus treatments: some progress, no panacea

Nearly a year after a mysterious pneumonia emerged in China and began its global spread, there is still no silver bullet treatment for COVID-19 despite an unprecedented effort to discover new medicines or repurpose existing ...

Arthritis & Rheumatism

New breakthrough in the treatment of rheumatoid arthritis

People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic ...

Arthritis & Rheumatism

Reducing dementia in patients with rheumatoid arthritis

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic ...

Diseases, Conditions, Syndromes

Minority patients with rheumatic diseases have worse COVID-19 outcomes

New research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized ...

page 36 from 40